We are live on ! Find out more
SCA

Stonebridge Capital Advisors Portfolio holdings

AUM $1.43B
1-Year Est. Return 21.98%
This Fund
S&P 500
This Quarter Est. Return
-11.66%
1 Year Est. Return
+21.98%
3 Year Est. Return
+64.22%
5 Year Est. Return
+80.67%
10 Year Est. Return
+293.7%
AUM
$825M
AUM Growth
-$100M
Cap. Flow
+$20.7M
Cap. Flow %
2.51%
Top 10 Hldgs %
24.59%
Holding
1,119
New
60
Increased
193
Reduced
253
Closed
162

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$7.4M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$5.44M
3
HD icon
Home Depot
HD
+$4.7M
4
CRM icon
Salesforce
CRM
+$4.6M
5
BLK icon
Blackrock
BLK
+$2.46M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$7.66M
2
CSCO icon
Cisco
CSCO
+$6.51M
3
CVX icon
Chevron
CVX
+$3.05M
4
T icon
AT&T
T
+$2.28M
5
IVZ icon
Invesco
IVZ
+$2.02M

Sector Composition

Rank Sector Weight
1 Technology 16.78%
2 Healthcare 13.57%
3 Financials 12.18%
4 Consumer Staples 10.33%
5 Communication Services 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTS icon
576
Zoetis
ZTS
$32.4B
$12K ﹤0.01%
70
AUY
577
DELISTED
Yamana Gold, Inc.
AUY
$12K ﹤0.01%
2,500
BLV icon
578
Vanguard Long-Term Bond ETF
BLV
$5.71B
$11K ﹤0.01%
138
+38
+38% +$3.13K
ET icon
579
Energy Transfer Partners
ET
$70.1B
$11K ﹤0.01%
1,122
KSS icon
580
Kohl's
KSS
$2.17B
$11K ﹤0.01%
300
OHI icon
581
Omega Healthcare
OHI
$15.1B
$11K ﹤0.01%
400
-100
-20% -$2.85K
RWL icon
582
Invesco S&P 500 Revenue ETF
RWL
$9.62B
$11K ﹤0.01%
162
VGT icon
583
Vanguard Information Technology ETF
VGT
$139B
$11K ﹤0.01%
264
DMK
584
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$11K ﹤0.01%
314
AXON
585
Axon Enterprise
AXON
$42.5B
$10K ﹤0.01%
103
+3
+3% +$317
BMO icon
586
Bank of Montreal
BMO
$126B
$10K ﹤0.01%
100
BPT
587
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$10K ﹤0.01%
500
BYM
588
DELISTED
BlackRock Municipal Income Quality Trust
BYM
$10K ﹤0.01%
833
CM icon
589
Canadian Imperial Bank of Commerce
CM
$108B
$10K ﹤0.01%
200
CMP icon
590
Compass Minerals
CMP
$1.23B
$10K ﹤0.01%
295
CSX icon
591
CSX Corp
CSX
$93.4B
$10K ﹤0.01%
330
-291
-47% -$9.49K
DHI icon
592
D.R. Horton
DHI
$40B
$10K ﹤0.01%
155
+100
+182% +$7.03K
DOV icon
593
Dover
DOV
$27.6B
$10K ﹤0.01%
83
FNDX icon
594
Schwab Fundamental US Large Company Index ETF
FNDX
$26.7B
$10K ﹤0.01%
+609
New +$11.2K
FSLR icon
595
First Solar
FSLR
$22.7B
$10K ﹤0.01%
150
IJT icon
596
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.26B
$10K ﹤0.01%
93
-30
-24% -$3.4K
IVT icon
597
InvenTrust Properties
IVT
$2.76B
$10K ﹤0.01%
396
-132
-25% -$3.86K
IVW icon
598
iShares S&P 500 Growth ETF
IVW
$73.8B
$10K ﹤0.01%
173
JCI icon
599
Johnson Controls International
JCI
$88.8B
$10K ﹤0.01%
207
-72
-26% -$4.01K
JPST icon
600
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
$10K ﹤0.01%
208

Similar funds

Stonebridge Capital Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Stonebridge Capital Advisors held 1,119 positions worth $825M, down 11% from $926M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Stonebridge Capital Advisors's Q2 2022 filing shows 60 new, 193 increased, 253 reduced and 162 closed positions. Its largest new stake was Winmark: 10,470 shares worth $2.05M. The largest sale was AbbVie, an estimated $7.66M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • Stonebridge Capital Advisors's largest Q2 2022 buy was Winmark: 10,470 shares worth $2.05M.
  • Stonebridge Capital Advisors added most to Oracle in Q2 2022, an estimated $7.4M increase.
  • Stonebridge Capital Advisors's biggest Q2 2022 reduction was AbbVie, cutting an estimated $7.66M.
  • Stonebridge Capital Advisors fully exited Hartford Multifactor Developed Markets ex-US ETF in Q2 2022, selling an estimated $215K.
  • Stonebridge Capital Advisors's ten largest holdings make up 25% of its $825M portfolio in Q2 2022.
  • Stonebridge Capital Advisors opened 60 new positions and closed 162 in Q2 2022.
  • Stonebridge Capital Advisors's portfolio value fell 11% quarter-over-quarter to $825M.

Based on Stonebridge Capital Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.